Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28014806 | 0.93 | THRB (0.64) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL22356498 | 0.90 | THRB (0.61) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL25830904 | 0.89 | THRB (0.75) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL1568935 | 0.89 | THRB (0.60) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL14195430 | 0.88 | THRB (0.54) | THRBKMT2AALDH1A1MEN1L3MBTL1 | |
| SCHEMBL25830880 | 0.86 | THRB (0.69) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL12925417 | 0.85 | THRB (0.47) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL16625918 | 0.84 | THRB (0.56) | THRBL3MBTL1TDP1LMNAMAPK1 | |
| SCHEMBL9633402 | 0.83 | THRB (0.78) | THRBKMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL20086240 | 0.83 | THRB (0.69) | THRBKMT2AKDM4EMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445653-B1 | PAINT COATING SYSTEM AND METHOD OF PRODUCING MULTILAYERED PAINT COATING | BASF SE (DE) | 2016-01-06 | — | — | EP | disclosed |
| EP-2445655-B1 | METHOD OF FORMING A CURED COATING COMPOSITION ON AN AUTOMOBILE COMPONENT | BASF SE (DE) | 2015-12-02 | — | — | EP | disclosed |
| EP-2445654-B1 | METHOD OF DISSOCIATING AN ORGANOBORANE-AMINE COMPLEX | BASF SE (DE) | 2015-11-25 | — | — | EP | disclosed |
| US-9080000-B2 | Method of forming a non-random copolymer | DOW CORNING CORPORATION (US) | 2015-07-14 | — | — | US | disclosed |
| EP-2393855-B1 | METHOD OF FORMING A NON-RANDOM COPOLYMER | DOW CORNING (US) | 2015-06-17 | — | — | EP | disclosed |
| US-8927062-B2 | Method of preparing a substrate with a composition including an organoborane initiator | DOW CORNING CORPORATION (US) | 2015-01-06 | — | — | US | disclosed |
| EP-1926602-B1 | AMBIENT LITHOGRAPHIC METHOD USING ORGANOBORANE AMINE COMPLEXES | DOW CORNING (US) | 2014-06-18 | — | — | EP | disclosed |
| US-8734944-B2 | Composite article | DOW CORNING CORPORATION (US) | 2014-05-27 | — | — | US | disclosed |
| US-8679585-B2 | Ambient lithographic method using organoborane amine complexes | DOW CORNING CORPORATION (US) | 2014-03-25 | — | — | US | disclosed |
| US-8653183-B2 | Method of curing a coating composition comprising a radical curable compound and an organoborane-amine complex | BASF SE (DE) | 2014-02-18 | — | — | US | disclosed |
| WO-2008085234-A1 | PROCESS FOR FORMING FILMS AND FILMS FORMED BY THE PROCESS | DOW CORNING CORPORATION (US) | 2008-07-17 | — | — | WO | disclosed |
| EP-1926602-A1 | AMBIENT LITHOGRAPHIC METHOD USING ORGANOBORANE AMINE COMPLEXES | Dow Corning Corporation (US) | 2008-06-04 | — | — | EP | disclosed |
| US-20080050552-A1 | Organosilicon Functional Boron Amine Catalyst Complexes and Curable Compositions Made Therefrom | DOW CORNING CORPORATION | 2008-02-28 | — | — | US | disclosed |
| EP-1866344-A1 | ORGANOSILLICON FUNCTIONAL BORON AMINE CATALYST COMPLEXES AND CURABLE COMPOSITIONS MADE THEREFROM | Dow Corning Corporation (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2007139596-A2 | BORANE CATALYST COMPLEXES WITH AMIDE FUNCTIONAL POLYMERS AND CURABLE COMPOSITIONS MADE THEREFROM | DOW CORNING CORPORATION (US) | 2007-12-06 | — | — | WO | disclosed |
| US-20070246245-A1 | Conductive Curable Compositions | DOW SILICONES CORPORATION | 2007-10-25 | — | — | US | disclosed |
| EP-1805256-A1 | CONDUCTIVE CURABLE COMPOSITIONS | Dow Corning Corporation (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2007040794-A1 | AMBIENT LITHOGRAPHIC METHOD USING ORGANOBORANE AMINE COMPLEXES | DOW CORNING CORPORATION (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2006073695-A1 | ORGANOSILLICON FUNCTIONAL BORON AMINE CATALYST COMPLEXES AND CURABLE COMPOSITIONS MADE THEREFROM | DOW CORNING CORPORATION (US) | 2006-07-13 | — | — | WO | disclosed |
| WO-2006049792-A1 | CONDUCTIVE CURABLE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080050552-A1 | Organosilicon Functional Boron Amine Catalyst Complexes and Curable Compositions Made Therefrom | DBF4, MCM6, FANCF | THRB 3981/4885KMT2A 1657/4885KDM4E 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.